Industry News
Pharmaceutical Industry News
GSK has launched the first…
GSK has launched the first direct-to-consumer TV spot for Exdensur, stepping up promotion of an asthma drug that the company is tipping to generate blockbuster sales.
Two different hacking rings…
Two different hacking rings acquired sensitive information from Novo and allegedly attempted to extort the company out of millions of dollars.
Amid multiple efforts to rein in…
Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own hands, albeit through a framework that may be difficult to pull off
Pharma companies have been part of…
Pharma companies have been part of the global economy and health systems for centuries. Now, as drugmakers play a more visible role in mainstream conversations about health and culture, Big Pharma is rethinking how it
With pharma and life sciences deal…
With pharma and life sciences deal values surpassing $65 billion in the first quarter, marking the strongest quarter in the industry since 2020, analysts from PwC have declared that the “biopharma ecosystem is back to
The program looks to support…
The program looks to support "faster, more coordinated approaches to emerging regulatory challenges and decisions," the United Kingdom's MHRA said.
As it prepares to launch up to…
As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. The company has hired Ester Banque to become its CCO and has elevated
Stealth BioTherapeutics is looking…
Stealth BioTherapeutics is looking to put its tumultuous path behind it with a new name.
Recipharm has sketched out a…
Recipharm has sketched out a “multi-million-dollar” investment in its U.S. manufacturing operations as part of a move to boost its sterile fill-finish capabilities and other production offerings for customers.
DeepIntent has launched an agentic…
DeepIntent has launched an agentic AI tool to help healthcare marketers more efficiently extract insights from databases using natural language.
U.S. pharmaceutical lobby group…
U.S. pharmaceutical lobby group PhRMA has launched a new ad offensive that looks to highlight the American life sciences industry’s ability to get new drugs to patients.
How the Kratom Industry Won Friends in the Trump Administration
A sprawling influence campaign to promote a risky drug called kratom has gained allies among top Trump administration officials. Our investigative reporter Kenneth P. Vogel explains.
Following criticism from…
Following criticism from drugmakers, Germany has scrapped its plan to install a program that would have reduced the prices of branded pharmaceuticals through a variable structure, according to a report from Reuters.
IQVIA Digital has developed…
IQVIA Digital has developed technology to help pharma marketers identify nurse practitioners and physician associates who write prescriptions.
The FDA approval clears Welireg’s…
The FDA approval clears Welireg's use with Keytruda in earlier-stage kidney cancer, following its 2023 solo nod for advanced disease.
Sanofi has gained an FDA expansion…
Sanofi has gained an FDA expansion for its Type 1 diabetes treatment Tzield. The decision came nearly two months after an original target date under former FDA chief Marty Makary’s controversial Commissioner’s National Priority Voucher
As the United Kingdom juggles…
As the United Kingdom juggles industry concerns about the region’s waning appeal and competitiveness, Eisai is getting a lift from a production-tinged fund that the British government first unveiled in 2024.
In patients with BTK-pretreated…
In patients with BTK-pretreated chronic lymphocytic leukemia, AbbVie and Roche’s Venclexta is the drug to beat. But no companies had taken a daunting head-to-head challenge—until Eli Lilly made the leap of faith with its Jaypirca.
Scientists Race to Test Treatments as Ebola Outbreak Widens
Trials are beginning on several drugs that have shown promise in preliminary studies against the virus that is causing the current outbreak.
J&J’s MonumenTAL-3 phase 3…
J&J's MonumenTAL-3 phase 3 study of bispecific antibody Talvey and Darzalex Faspro in patients with earlier-stage multiple myeloma earned a plenary spot at the 2026 European Hematology Association annual meeting.